104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
Benedikt Schoser, Priya S. Kishnani, Drago Bratkovic, Barry J. Byrne et autres
de, us, au, be, gb, fr, it, nl (code pays fourni par la source)